000 01116 a2200325 4500
005 20250511185404.0
264 0 _c19930204
008 199302s 0 0 eng d
022 _a0271-0749
040 _aNLM
_beng
_cNLM
100 1 _aBrown, D W
245 0 0 _aCarbamazepine-induced increases in total serum cholesterol: clinical and theoretical implications.
_h[electronic resource]
260 _bJournal of clinical psychopharmacology
_cDec 1992
300 _a431-7 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
650 0 4 _aAdult
650 0 4 _aAffective Disorders, Psychotic
_xdrug therapy
650 0 4 _aCarbamazepine
_xadverse effects
650 0 4 _aCholesterol
_xblood
650 0 4 _aChromatography, High Pressure Liquid
650 0 4 _aDissociative Identity Disorder
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
700 1 _aKetter, T A
700 1 _aCrumlish, J
700 1 _aPost, R M
773 0 _tJournal of clinical psychopharmacology
_gvol. 12
_gno. 6
_gp. 431-7
999 _c1480669
_d1480669